Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Hu

Showing results (1061-1070 of 1,908) with videos related to

Pageof 191
Sort By:
Virology Journal|April 3, 2024
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapyHsin-Wei Fang, Po-Lin Tseng, Tsung-Hui Hu, et al.
American Journal of Cancer Research|June 11, 2024
Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosisChien-Hung Chen, Jing-Houng Wang, Hsueh-Chou Lai, et al.
Biomedical Journal|July 6, 2026
Association of HBsAg levels and HBV relapse patterns with HBsAg seroclearance following entecavir or tenofovir cessationYuan-Hung Kuo, Yi-Hao Yen, Tsung-Hui Hu, et al.
Medicine|July 7, 2019
Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practiceYi-Hao Yen, Fang-Ying Kuo, Chien-Hung Chen, et al.
International Journal of Cancer|July 30, 2010
Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapyChao-Hung Hung, Chuan-Mo Lee, Jing-Houng Wang, et al.
World Journal of Clinical Cases|January 8, 2019
Safety of fecal microbiota transplantation in Chinese children: A single-center retrospective studyXin-Yue Zhang, Yi-Zhong Wang, Xiao-Lu Li, et al.
Plos One|April 17, 2020
Factors influencing participant compliance in acupuncture trials: An in-depth interview studyHui-Juan Cao, Xun Li, Xin-Lin Li, et al.
Medicine|May 9, 2020
Clinical study of XiangShaLiuJunZi decoction combined with S-1 as maintenance therapy for stage III or IV gastric carcinoma and colorectal carcinomaXiao-Cui Hong, Qi-Lian Liang, Xing-Bo Luo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 21, 2016
Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patientsChuan-Mo Lee, Tsung-Hui Hu, Sheng-Nan Lu, et al.
The Kaohsiung Journal of Medical Sciences|October 23, 2021
Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virusYuan-Hung Kuo, Kwong-Ming Kee, Chao-Hung Hung, et al.
Pageof 191

Showing results (1061-1070 of 1,908) with videos related to

Sort By:
Pageof 191
Virology Journal|April 3, 2024
Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapyHsin-Wei Fang, Po-Lin Tseng, Tsung-Hui Hu, et al.
American Journal of Cancer Research|June 11, 2024
Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosisChien-Hung Chen, Jing-Houng Wang, Hsueh-Chou Lai, et al.
Biomedical Journal|July 6, 2026
Association of HBsAg levels and HBV relapse patterns with HBsAg seroclearance following entecavir or tenofovir cessationYuan-Hung Kuo, Yi-Hao Yen, Tsung-Hui Hu, et al.
Medicine|July 7, 2019
Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practiceYi-Hao Yen, Fang-Ying Kuo, Chien-Hung Chen, et al.
International Journal of Cancer|July 30, 2010
Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapyChao-Hung Hung, Chuan-Mo Lee, Jing-Houng Wang, et al.
World Journal of Clinical Cases|January 8, 2019
Safety of fecal microbiota transplantation in Chinese children: A single-center retrospective studyXin-Yue Zhang, Yi-Zhong Wang, Xiao-Lu Li, et al.
Plos One|April 17, 2020
Factors influencing participant compliance in acupuncture trials: An in-depth interview studyHui-Juan Cao, Xun Li, Xin-Lin Li, et al.
Medicine|May 9, 2020
Clinical study of XiangShaLiuJunZi decoction combined with S-1 as maintenance therapy for stage III or IV gastric carcinoma and colorectal carcinomaXiao-Cui Hong, Qi-Lian Liang, Xing-Bo Luo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 21, 2016
Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patientsChuan-Mo Lee, Tsung-Hui Hu, Sheng-Nan Lu, et al.
The Kaohsiung Journal of Medical Sciences|October 23, 2021
Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virusYuan-Hung Kuo, Kwong-Ming Kee, Chao-Hung Hung, et al.
Pageof 191